{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:58:44Z","timestamp":1790110724774,"version":"4.0.1"},"reference-count":31,"publisher":"American Diabetes Association","issue":"5","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,5,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Recent evidence suggests that poor glycemic control is significantly associated with the development of macrovascular complications of diabetes. Studies have indicated that C-reactive protein (CRP) is an important risk factor for cardiovascular disease. The purpose of this study was to determine the relation between CRP and HbA1c in a large national sample of individuals with diabetes.<\/jats:p>\n                  <jats:p>RESEARCH DESIGN AND METHODS\u2014A nationally representative sample of noninstitutionalized U.S. adults aged 17 years and over with nongestational diabetes was derived from the National Health and Nutrition Examination Survey III (1988\u20131994) (n = 1,018). Respondents with diabetes were stratified by HbA1c level. The main outcome measure was elevated (&amp;gt;0.30 mg\/dl) CRP.<\/jats:p>\n                  <jats:p>RESULTS\u2014In unadjusted analyses, respondents with diabetes who had elevated HbA1c levels (\u22659.0%) had a significantly higher percent of elevated CRP than people with low (&amp;lt;7%) HbA1c levels (P &amp;lt; 0.001). In adjusted regression analysis, after controlling for age, race, sex, smoking, length of time with diabetes, insulin, and BMI, HbA1c was significantly associated with an increased likelihood of elevated CRP for HbA1c &amp;gt;9.0% (OR 2.15, 95% CI 1.07\u20134.32) and for HbA1c &amp;gt;11.0% (4.40, 1.87\u201310.38). Higher HbA1c also predicted elevated CRP in the regression model when HbA1c was analyzed as a continuous variable (1.20, 1.07\u20131.34).<\/jats:p>\n                  <jats:p>CONCLUSIONS\u2014In this study, the likelihood of elevated CRP concentrations increased with increasing HbA1c levels. These findings suggest an association between glycemic control and systemic inflammation in people with established diabetes.<\/jats:p>","DOI":"10.2337\/diacare.26.5.1535","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T17:51:27Z","timestamp":1173117087000},"page":"1535-1539","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":208,"title":["C-Reactive Protein and Glycemic Control in Adults With Diabetes"],"prefix":"10.2337","volume":"26","author":[{"given":"Dana E.","family":"King","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Arch G.","family":"Mainous","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Buchanan","sequence":"additional","affiliation":[{"name":"General Clinical Research Center, University of Southern California School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Pearson","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031216471899600_R1","doi-asserted-by":"crossref","unstructured":"Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A, Loubinoux J, Le Faou A, Gueant JL: C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J\u2008137:346\u2013351, 1999","DOI":"10.1053\/hj.1999.v137.92052"},{"key":"2022031216471899600_R2","doi-asserted-by":"crossref","unstructured":"Ridker PM, Rifai N, Lowenthal SP: Rapid reduction of C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation\u2008103:1191\u20131193, 2001","DOI":"10.1161\/01.CIR.103.9.1191"},{"key":"2022031216471899600_R3","doi-asserted-by":"crossref","unstructured":"Ridker PM, Glynn RJ, Hennekens CH: C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation\u200897:2007\u20132011, 1998","DOI":"10.1161\/01.CIR.97.20.2007"},{"key":"2022031216471899600_R4","doi-asserted-by":"crossref","unstructured":"Kervinen H, Palosuo T, Manninen V, Tenkanen L, Vaarala O, Manttari M: Joint effects of C-reactive protein and other risk factors on acute coronary events. Am Heart J\u2008141:580\u2013585, 2001","DOI":"10.1067\/mhj.2001.113572"},{"key":"2022031216471899600_R5","doi-asserted-by":"crossref","unstructured":"Ridker PM, Stampfer MJ, Rifai N: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA\u2008285:2481\u20132485, 2001","DOI":"10.1001\/jama.285.19.2481"},{"key":"2022031216471899600_R6","doi-asserted-by":"crossref","unstructured":"Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA\u2008286:327\u2013334, 2001","DOI":"10.1001\/jama.286.3.327"},{"key":"2022031216471899600_R7","doi-asserted-by":"crossref","unstructured":"Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP: The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes\u200850:2384\u20132389, 2001","DOI":"10.2337\/diabetes.50.10.2384"},{"key":"2022031216471899600_R8","doi-asserted-by":"crossref","unstructured":"Ford ES: Body mass index, diabetes, and C-reactive protein among U.S. Adults. Diabetes Care\u200822:1971\u20131977, 1999","DOI":"10.2337\/diacare.22.12.1971"},{"key":"2022031216471899600_R9","doi-asserted-by":"crossref","unstructured":"Grau AJ, Buggle F, Becher H, Werle E, Hacke W: The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res\u200882:245\u2013255, 1996","DOI":"10.1016\/0049-3848(96)00071-0"},{"key":"2022031216471899600_R10","doi-asserted-by":"crossref","unstructured":"Goldberg RB: Cardiovascular disease in diabetic patients. Med Clin North Am\u200884:81\u201393, 2000","DOI":"10.1016\/S0025-7125(05)70208-X"},{"key":"2022031216471899600_R11","doi-asserted-by":"crossref","unstructured":"Wu T, Dorn JP, Donahue RP, Sempos CT, Trevisan M: Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin. Am J Epidemiol\u2008155:65\u201371, 2002","DOI":"10.1093\/aje\/155.1.65"},{"key":"2022031216471899600_R12","doi-asserted-by":"crossref","unstructured":"Rodriguez-Moran M, Guerrero-Romero F: Increased levels of C-reactive protein in noncontrolled type II diabetic subjects. J Diabetes Complications\u200813:211\u2013215, 1999","DOI":"10.1016\/S1056-8727(99)00047-1"},{"key":"2022031216471899600_R13","doi-asserted-by":"crossref","unstructured":"Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald: Long-term effects of pravastatin on plasma concentration of c-reactive protein. Circulation\u2008100:230\u2013235, 1999","DOI":"10.1161\/01.CIR.100.3.230"},{"key":"2022031216471899600_R14","doi-asserted-by":"crossref","unstructured":"Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med\u2008336:973\u2013979, 1997","DOI":"10.1056\/NEJM199704033361401"},{"key":"2022031216471899600_R15","unstructured":"Gunter EW, Lewis BG, Koncikowski SM: Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988\u20131994. Atlanta, GA, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Environmental Health, 1996"},{"key":"2022031216471899600_R16","doi-asserted-by":"crossref","unstructured":"Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med\u2008347:1557\u20131565, 2002","DOI":"10.1056\/NEJMoa021993"},{"key":"2022031216471899600_R17","unstructured":"Wener MH, Daum PR, McQuillan GM: The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol\u200827:2351\u20132359, 2000"},{"key":"2022031216471899600_R18","doi-asserted-by":"crossref","unstructured":"Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH: Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol\u200817:2167\u20132176, 1997","DOI":"10.1161\/01.ATV.17.10.2167"},{"key":"2022031216471899600_R19","doi-asserted-by":"crossref","unstructured":"American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care\u200825(Suppl. 1):S33\u2013S49, 2002","DOI":"10.2337\/diacare.25.2007.S33"},{"key":"2022031216471899600_R20","doi-asserted-by":"crossref","unstructured":"Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet\u2008353:1649\u20131652, 1999","DOI":"10.1016\/S0140-6736(99)01046-6"},{"key":"2022031216471899600_R21","doi-asserted-by":"crossref","unstructured":"Festa A, D\u2019Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation\u2008102:42\u201347, 2000","DOI":"10.1161\/01.CIR.102.1.42"},{"key":"2022031216471899600_R22","doi-asserted-by":"crossref","unstructured":"Festa A, D\u2019Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes\u200851:1131\u20131137, 2002","DOI":"10.2337\/diabetes.51.4.1131"},{"key":"2022031216471899600_R23","doi-asserted-by":"crossref","unstructured":"Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol\u200819:972\u2013978, 1999","DOI":"10.1161\/01.ATV.19.4.972"},{"key":"2022031216471899600_R24","doi-asserted-by":"crossref","unstructured":"Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM: Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation\u2008102:1000\u20131006, 2000","DOI":"10.1161\/01.CIR.102.9.1000"},{"key":"2022031216471899600_R25","doi-asserted-by":"crossref","unstructured":"Fro\u0308hlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W: Association between C-reactive protein and features of the metabolic syndrome: A population-based study. Diabetes Care\u200823:1835\u20131839, 2000","DOI":"10.2337\/diacare.23.12.1835"},{"key":"2022031216471899600_R26","doi-asserted-by":"crossref","unstructured":"Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P: Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab\u200885:2970\u20132973, 2000","DOI":"10.1210\/jcem.85.8.6854"},{"key":"2022031216471899600_R27","doi-asserted-by":"crossref","unstructured":"Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P: Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr\u200875:767\u2013772, 2002","DOI":"10.1093\/ajcn\/75.4.767"},{"key":"2022031216471899600_R28","doi-asserted-by":"crossref","unstructured":"Dandona P, Aljada A: A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis. Am J Cardiol\u200890 (Suppl. 5A):27G\u201333G, 2001","DOI":"10.1016\/S0002-9149(02)02556-0"},{"key":"2022031216471899600_R29","doi-asserted-by":"crossref","unstructured":"Wei M, Gaskill SP, Haffner SM, Stern MP: Effects of diabetes and level of glycemia on all-cause mortality: the San Antonio Heart Study. Diabetes Care\u200821:1167\u20131172, 1998","DOI":"10.2337\/diacare.21.7.1167"},{"key":"2022031216471899600_R30","doi-asserted-by":"crossref","unstructured":"Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS 23). BMJ\u2008316:823\u2013828, 1998","DOI":"10.1136\/bmj.316.7134.823"},{"key":"2022031216471899600_R31","doi-asserted-by":"crossref","unstructured":"Chu NV, Kong APS, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD: Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care\u200825:542\u2013549, 2002","DOI":"10.2337\/diacare.25.3.542"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/5\/1535\/591688\/dc0503001535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/5\/1535\/591688\/dc0503001535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T12:22:16Z","timestamp":1647087736000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/26\/5\/1535\/24460\/C-Reactive-Protein-and-Glycemic-Control-in-Adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.26.5.1535","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,1]]}}}